Woudenberg Michael's most recent trade in InMed Pharmaceuticals Inc was a trade of 18,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,000 | 25,445 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | 15 Dec 2025 | 60 | 7,445 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Woudenberg Michael | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 3,750 | 7,505 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | 27 May 2024 | 394 | 75,100 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 65,000 | 75,494 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Woudenberg Michael | Chief Operating Officer | 05 Dec 2023 | 848 | 10,494 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 7,500 | 11,342 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 7,500 | 11,342 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Michael Woudenberg | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 5,000 | 96,060 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Michael Woudenberg | VP, Chem/Manufacturing/Control | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 30,000 | 91,060 | - | - | Employee Stock Option (Right to Buy) |